Cardiovascular Journal of Africa: Vol 27 No 2 (March/April 2016)

49 / 72

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 2, March/April 2016 AFRICA 103
50. Karamitsos TD, Francis JM, Myerson SG, Selvanayagam JB, Neubauer
S. The role of cardiovascular magnetic resonance imaging in heart fail-
ure. J Am Coll Cardiol 2009; 54(15): 1407–1424.
51. Ain DL, Narula J, Sengupta PP. Cardiovascular imaging and diagnostic
procedures in pregnancy. Cardiol Clin 2012; 30(3): 331–341.
52. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast
agents. J Magn Reson Imag 1999; 10: 477–484.
53. Mevissen M, Buntenkotter S, Loscher W. Effects of static and time-
varying (50 Hz) magnetic fields on reproduction and fetal development
in rats. Teratology 1994; 50: 229–237.
54. Beers GJ. Biological effects of weak electromagnetic fields from 0 Hz
to 200 Hz: a survey of the literature with special emphasis on possible
magnetic resonance effects. Mag Res Imag 1989; 7: 309–331.
55. Schwartz JL, Crooks LE. NMR imaging produces no observable muta-
tions or cytotoxicity in mammalian cells. Am J Roentgenol 1982; 139:
583–585.
56. Wolff S, Crooks LE, Brown P, Howard R, Painter R. Test for DNA and
chromosomal damage induced by nuclear magnetic resonance imaging.
Radiology 1980; 136: 707–710.
57. Reeves MJ, Brandreth M, Whitby EH, Hart AR, Paley MN, Griffiths
PD, et al. Neonatal cochlear function: measurement after exposure
to acoustic noise during in utero MR imaging. Radiology 2010; 257:
802–809.
58. American College of Radiology. ACR-SPR practice parameter for the
safe and optimal performance of fetal magnetic resonance imaging
(MRI). Revised 2015 (Resolution 11). Available at:
media/CB384A65345F402083639E6756CE513F.pdf
59. Berman DS, Hachamovitch R, Shaw LJ, Friedman JD, Hayes SW,
Thomson LE, et al. Roles of nuclear cardiology, cardiac computed
tomography, and cardiac magnetic resonance: assessment of patients
with suspected coronary artery disease. J Nucl Med 2006; 47(1): 78–82.
60. Harper PV, Lathrop KA, Jiminez F, Fink R, Gottschalk A. Technetium
99m as a scanning agent. Radiology 1965; 85: 101–109.
61. Schembri GP, Miller AE, Smart R. Radiation dosimetry and safety
issues in the investigation of pulmonary embolism. Semin Nucl Med
2010; 40: 442–454.
62. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischaemic
heart disease: basic principles and application to imaging by positron
emission tomography. Prog Cardiovasc Dis 1989; 32(3): 217–238.
63. Saha, GB. Basics of PET Imaging: Physics, Chemistry and Regulations
(2nd edn). New York: Springer, 2010.
64. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, et al .
Exposure to low-dose ionizing radiation from medical imaging. New
Engl Med J 2009; 361: 849–857.
65. Khalil MM, Tremoleda JL, Bayomy TB, Gsell W. Molecular SPECT
Imaging: An overview. Int J Mol Imag 2011: 2011: 796025.
66. Paul AK, Nabi HA. Gated myocardial perfusion SPECVT: Basic prin-
ciples, technical aspects, and clinical applications. J Nucl Med Technol
2004; 32(4): 179–187.
67. Ralston WH, Robbins MS, James P. Reproductive, developmental, and
genetic toxicity of ioversol. Invest Radiol 1989; 24(Suppl 1): 16–22.
68. Mehta PS, Metha SJ, Vorherr H. Congenital iodide goiter and hypothy-
roidism: a review. Obstet Gynecol Surv 1983; 38: 237–247.
69. Webb JA, Thomsen HS, Morcos SK; Members of Contrast Media
Safety Committee of European Society of Urogenital Radiology
(ESUR). The use of iodinated and gadolinium contrast media during
pregnancy and lactation. Eur Radiol 2005; 15: 1234–1240.
70. Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of
radiologic procedures used in the diagnosis of maternal venous throm-
boembolic disease. Thromb Haemost 1989; 61: 189–196.
71. Okuda Y, Sagami F, Tirone P, Morisetti A, Bussi S, Masters RE.
Reproductive and developmental toxicity study of gadobenate dimeglu-
mine formulation (E7155) (3) Study of embryo-fetal toxicity in rabbits
by intravenous administration. J Toxicol Sci 1999; 24(Suppl 1): 79–87.
72. Garcia-Bournissen F, Shrim A, Koren G. Safety of gadolinium during
pregnancy. Can Fam Physician 2006; 52(3): 309–310.
73. Spencer JA, Tomlinson AJ, Weston MJ, Lloyd SN. Early report:
comparison of breath-hold MR excretory urography, Doppler ultra-
sound and isotope renography in evaluation of symptomatic hydrone-
phrosis in pregnancy. Clin Radiol 2000; 55: 446–453.
74. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG, Jr., Froelich
JW, et al. ACR guidance document for safe MR practices: 2007. Am J
Roentgenol 2007; 188: 1447–1474.
75. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG, Froelich JW,
et al. ACR Guidance document on MR safe practices: 2013. J Magn
Reson Imag 2013; 37: 501–530.